Catégorie : Points saillants de la recherche

New Investments in Global-leading, Alberta-based Genomics Technology Platforms to Advance Services

New Investments in Global-leading, Alberta-based Genomics Technology Platforms to Advance Services

Genome Canada and Genome Alberta recently announced an investment of $1M in GlycoNet Integrated Services (GIS) to develop and expand glycomics services with applications in health, agriculture and bio-based industries.

GlycoNet investigators identify a cancer-associated sugar as a new biomarker for scleroderma

GlycoNet investigators identify a cancer-associated sugar as a new biomarker for scleroderma

A sugar that’s been linked to cancer could also serve as an early indicator of severe scleroderma, improving diagnosis and treatment options for patients with this rare disease.

Cracking the Code of Cellular Health: Dr. Vocadlo’s Pioneering Research

Cracking the Code of Cellular Health: Dr. Vocadlo’s Pioneering Research

GlycoNet Investigator’s discovery provides insight into a vital cellular process that could be leveraged to unlock new therapeutic pathways for neurodegenerative diseases and cancer.

fr_CAFrench
Remonter en haut de la page